Community-Based Diabetes Care for Korean American Immigrants

Completed · Not applicable

Conditions studied: Type 2 Diabetes

In brief

The primary aims are to test the effectiveness of the self-help DM intervention (SHIP-DM), a comprehensive, culturally tailored DM management intervention, in improving glucose outcomes; To determine the effectiveness of the SHIP-DM in KAI with type 2 DM in improving self-care skills and psycho-behavioral outcomes related to DM control, to develop tangible infrastructures for the dissemination of valid and effective education materials to a wider population of KAI with type 2 DM in the US (e.g., audio-visual education materials, web-based intervention materials, mobile telephone-based intervention materials) and to explore the feasibility and acceptability of each dissemination module, utilizing the delayed intervention group participants. The secondary aims are to obtain preliminary cost-effectiveness data related to the proposed intervention, including cost estimates for this type of DM intervention, and to establish a systematic, long-term dissemination plan, including documenting effective methodologies, to facilitate faster translation of research findings and products to direct consumers in non-research settings.

Key facts

Study ID

NCT01264796

Run by

University of Texas at Austin

People needed

250

Starts

2009-11-01

Expected to finish

2015-08-01

Last updated by the study team

2017-03-08

Who can join

Age: 30 and older, up to 75. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Self-identified as a first generation Korean American
• Type 2 diabetes
• Age 30-75 years
• Resides in Washington-Baltimore area
• Self-identified with DM and HbA1c >= 7.0 % within 6 months of screening
• Expresses willingness to participate in all aspects of the study over its full course

You may not qualify if…

• Unable to give informed consent
• Physical or mental health conditions that could limit active participation in the study (e.g., blindness in both eyes, severe immobility, psychiatric diseases)
• Hematological condition that would affect A1C assay, e.g., hemolytic anemia, sickle cell anemia
• Past experience in diabetes group education

Where it is running

• Johns Hopkins University — Baltimore, Maryland, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.